Jump to content

Estrone tetraacetylglucoside

From Wikipedia, the free encyclopedia
Estrone tetraacetylglucoside
Identifiers
  • [(2R,3R,4S,5R,6S)-3,4,5-triacetyloxy-6-{[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy}oxan-2-yl]methyl acetate
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC32H40O11
Molar mass600.661 g·mol−1
3D model (JSmol)
  • CC(=O)OCC1OC(Oc2ccc3C4CCC5(C)C(CCC5=O)C4CCc3c2)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O
  • InChI=1S/C32H40O11/c1-16(33)38-15-26-28(39-17(2)34)29(40-18(3)35)30(41-19(4)36)31(43-26)42-21-7-9-22-20(14-21)6-8-24-23(22)12-13-32(5)25(24)10-11-27(32)37/h7,9,14,23-26,28-31H,6,8,10-13,15H2,1-5H3
  • Key:IMZSXCARTLIDBP-UHFFFAOYSA-N

Estrone tetraacetylglucoside (brand name Glucovex, Glycovex) is a semisynthetic, steroidal estrogen.[1] It is an estrogen ester, specifically, an ester of estrone.[1] The drug was marketed since at least 1942.[2]

References

[edit]
  1. ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 900. ISBN 978-1-4757-2085-3.
  2. ^ Jacobson O (1947). Heredity in breast cancer, a genetic and clinical study of two hundred probands. Munksgaard. p. 251. {{cite book}}: |work= ignored (help)